Dynamic Ultrasound Molecular-Targeted Imaging of Senescence in Evaluation of Lapatinib Resistance in HER2-Positive Breast Cancer

Scientists established a new cellular model of reversible cellular senescence using lapatinib (LAP) and HER2+ breast cancer cells and found that reversible senescence contributed to LAP resistance in HER2+ breast cancer.